Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa

NCT04582669 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.

NCT NCT04582669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04582669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa
Lead sponsor
Montefiore Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
January 24, 2022
Completion date
October 12, 2022
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa